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Abstract
Introduction An excessive inflammatory response is thought to
account for the pathogenesis of sepsis and multiple organ
dysfunction syndrome (MODS) after severe trauma. The
interleukin-10 (IL-10) is a potent anti-inflammatory cytokine. The
objectives of this prospective study were to investigate the
distribution of IL-10 promoter polymorphisms in a cohort of 308
Chinese Han patients with major trauma, and to identify
associations of IL-10 promoter polymorphisms with IL-10
production and incidence of sepsis and MODS.
Methods A total of 308 patients with major trauma were
included in this study. The genotypes of polymorphisms -1082,
-819 and -592 were determined by polymerase chain reaction-
restriction fragment length polymorphism. The IL-10 levels in the
supernatants were determined with enzyme-linked
immunoabsorbent assay.
Results The -1082A and -592A alleles were significantly
associated with lower lipopolysaccharide-induced IL-10
production in an allele-dose dependent fashion. There was no
significant difference for the -819 polymorphism. Except for the
-1082 polymorphism, the -819 and -592 polymorphisms were
not significantly associated with sepsis morbidity rate and MOD
scores.
Conclusions Our results further confirm the functionality of the
IL-10 promoter single nucleotide polymorphisms in relation to IL-
10 production. They also suggest that individual difference in IL-
10 production in trauma patients might be at least in part related
to genetic variations in the IL-10 promoter region.
Introduction
Trauma, a major public health problem worldwide, ranks as the
fourth leading cause of death among all diseases [1]. One of
the most serious complications of major trauma is the sequen-
tial dysfunction of vital organs, which is associated with post-
traumatic sepsis in the majority of cases [2]. Therefore, pre-
venting sepsis and subsequent organ dysfunction is crucial in
the treatment of surviving patients with major trauma. It has
been demonstrated that inappropriate immune inflammatory
response contributes to the development of sepsis and multi-
ple organ dysfunction syndrome (MODS) in major trauma
patients [3,4]. Increasing evidence suggests that genetic vari-
ants, particularly single nucleotide polymorphisms (SNPs), are
critical determinants for inter-individual differences in both
inflammatory responses and clinical outcome in trauma
patients [5,6]. Delineating the variation in genes and associ-
CI: confidence interval; ELISA: enzyme-linked immunosorbent assay; IFN-γ: interferon-γ; IL-10: interleukin-10; ISS: Injury Severity Score; LPS: lipopol-
ysaccharide; MODS: multiple organ dysfunction syndrome; OR: odds ratios; PCR: polymerase chain reaction; RFLP: restriction fragment length pol-
ymorphism; SNPs: single nucleotide polymorphisms; TNF-α: tumor necrosis factor alpha.Critical Care    Vol 13 No 6    Zeng et al.
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ated differences in response to trauma may contribute to the
development of new genetically tailored diagnostic and thera-
peutic interventions that will improve outcome in the patients
with major trauma.
IL-10 is one of the key anti-inflammatory cytokines and it
decreases the production of inflammatory molecules, such as
TNF-α, interferon (IFN)-γ, IL-12, reactive nitric oxide metabo-
lites, major histocompatibility complex molecules [7] and inhib-
its antigen-specific cytotoxic T cells [8]. The magnitude of the
proinflammatory cytokine response, neutrophil infiltration, and
injury were shown to be greater in IL-10(-/-)-null mice after vis-
ceral ischemia-reperfusion injury. Administration of exogenous
IL-10 results in a decrease in neutrophil infiltration in IL-10(-/-)-
null mice [9]. It suggests that lower producers of IL-10 might
be sensitive to the development of sepsis and MODS due to
its ability to suppress inflammation. IL-10 has been shown to
be elevated after trauma [10] and is well correlated with the
development of sepsis and outcome in patients with major
trauma [11,12]. Previous studies have demonstrated that the
variation in IL-10 production is largely genetically determined,
which is mainly related to genetic variations in the promoter
region [13,14]. The IL-10 5'-flanking region, which controls
transcription, is polymorphic, with two microsatellites between
-4000 and -1100, and three SNPs (-1082, -819, and -592)
[15]. The -1082, -819 and -592 polymorphisms are shown to
be in close linkage disequilibrium and construct only three
haplotypes in the white population (GCC, ACC and ATA in an
order of -1089/-819/-592) [16]. These haplotypes are associ-
ated with high (GCC), intermediate (ACC), and low (ATA) IL-
10 production [14]. Genetic association studies have indi-
cated that the three SNPs in the IL-10 promoter are linked to
various diseases, such as Crohn's disease [16], schizophrenia
[17], hepatitis [18], endometriosis [19], Alzheimer's disease
[20], acute respiratory distress syndrome [21] and sepsis
[22]. However, clinical relevance of the three SNPs is still not
fully understood, due to considerable controversy in the litera-
ture regarding the influence of these SNPs on susceptibility to
diseases and their functionality [23-25]. Schroeder and col-
leagues [23,26] reported the association of the IL-10 with the
-1082 and -592 polymorphisms with the incidence of MODS
and acute respiratory failure in patients with major trauma,
respectively, and also showed inconsistent results.
In this study we investigated whether the genetic variations at
positions -1082, -819 and -592 in the IL-10 promoter affect IL-
10 production after trauma, and whether there is an associa-
tion of these polymorphisms with the development of post-
traumatic sepsis and MODS. Our hypothesis was that geneti-
cally determined lower production of IL-10 might increase sus-
ceptibility to post-traumatic complications.
Materials and methods
Study population
A total of 308 patients with major trauma (240 male and 68
female) were prospectively recruited in this study. All of them
are Han Chinese and live in Chongqing district. The patients
were consecutively admitted to the Department of Trauma
Surgery in the Daping Hospital and the Chongqing Emer-
gency Medical Center between 1 January, 2005 and 1 June,
2008. They were enrolled in the study if they met the following
criteria: (1) aged between 18 and 65 years; (2) expected Injury
Severity Score (ISS) greater than 16 combined with the pres-
ence of at least one life-threatening injury and at least one
additional severe injury in another part of the body and (3)
probability of survival greater than 48 hours. Patients were not
eligible if they had penetrating injuries, or pre-existing cardio-
vascular, respiratory, renal, hepatic, hematologic or immuno-
logical diseases. ISS was performed according to the
Abbreviated Injury Scale 2005 by independent evaluators
[27]. All patients requiring surgical intervention received
standard surgical care and postoperative intensive care unit
treatment. The protocol for this study was approved by the
Ethical and Protocol Review Committee of the Third Military
Medical University, and informed consent was obtained from
the patients or the patient's next of kin.
Genotyping of the IL-10 promoter polymorphisms
Blood specimens were collected in tripotassium ethylenedi-
amine tetraacetic acid sterile tubes from trauma patients
immediately after admission (generally within 10 hours after
injury) in order to avoid the effect of blood transfusion. The
genomic DNA was isolated from whole blood using Wizard
genomic DNA purification kit (Promega, Madison, WI, USA)
according to the manufacturer's protocol. A PCR-restriction
fragment length polymorphism (RFLP) method was used to
detect the IL-10 promoter polymorphisms. The oligonucle-
otide primers for amplification and PCR conditions were
shown in Table 1. PCR products were digested with XagI,
Hin1α or Rsa I (New England Biolabs, Beverly, MA, USA) for
one hours at 37°C. The SNPs were then genotyped by frag-
ment size obtained after agarose gel electrophoresis, which
were further confirmed by DNA sequencing of the IL-10 pro-
moter with 10 random samples (Takara Biotech, Dalian,
China). The genotyping was performed in a blinded fashion
such that those analyzing the genotype data did not know any
other experimental results.
Ex vivo IL-10 production
A human whole-blood assay was used as described previously
[6]. In brief, aliquots of whole blood collected from the trauma
patients were mixed in a ratio of 1:1 with Roosevelt Park
Memorial Institute medium 1640, and incubated with 100 ng/
ml lipopolysaccharide (LPS; Escherichia coli O26:B6, Difco
Laboratories, Detroit, MI, USA) in a sample mixer at 37°C for
four hours. The supernatants were then separated by centrifu-
gation. The IL-10 levels in the supernatants were determinedAvailable online http://ccforum.com/content/13/6/R188
Page 3 of 8
(page number not for citation purposes)
by ELISA according to the manufacturer's instructions (R & D
System, Minneapolis, MN, USA). The lower limit for detection
was 4 pg/ml. Variability between triplicate wells was less than
5%.
Clinical evaluation
After admission, the patients with major trauma were moni-
tored in the following aspects: respiratory (partial pressure of
arterial oxygen/fraction of inspired oxygen ratio), renal (serum
creatinine concentration), hepatic (serum bilirubin concentra-
tion), cardiovascular (pressure-adjusted heart rate) and hema-
tologic (platelet count) systems. The organ function was then
scored using the method of Marshall and colleagues [28] and
calculated as a single daily value during the intensive care unit
stay. Neurological scoring was not performed because every
patient was sedated. Sepsis was defined if patients met all the
following criteria: clinical evidence of infection, body tempera-
ture greater than 38.5°C or less than 36.5°C, and leukocyte
count greater than 10 × 109/L or less than 4 × 109/L. The
MODS scores and sepsis were determined by individuals who
did not know the genotypes.
Statistical analysis
Sample size was calculated using online Power and Sample
Size Program software [29]. The desired power of our study
was set at 80% with a significance level of 0.05 in a two-sided
test. We chose the log-additive inheritance model, which is the
most suitable for polygenic diseases. By means of the Power
and Sample Size program, our sample (n = 308) was consid-
ered adequate to study the -1082, -819 and -592 polymor-
phisms.
Allele frequencies for each SNP were determined by gene
counting. Any deviation from Hardy-Weinberg equilibrium was
calculated by a chi-squared goodness-of-fit test. The chi-
squared test or Fisher's exact test was used to determine dif-
ferences in frequencies of the IL-10 promoter polymorphisms
among trauma patients with different genotypes. Odds ratios
(OR) and 95% confidence intervals (CI) were calculated using
logistic regression models whenever that chi-squared or
Fisher's exact test was significant. The association of the IL-10
promoter polymorphisms with plasma IL-10 levels and MODS
scores was determined using one-way analysis of variance.
Three genetic models (allele-dose, dominant, and recessive)
were used. Significant probability values obtained were cor-
rected for multiple testing (Bonferroni correction). P values
less than 0.05 were considered significant. All statistic analy-
sis was carried out using SPSS Version 11.0 (SPSS Inc, Chi-
cago, Illinois, USA).
Results
Overall clinical characteristics of patients with major 
trauma
The patient cohort comprised a total of 308 consecutive Han
Chinese patients with severe multiple trauma. Trauma was
caused by traffic accidents (n = 187), falling (n = 105), or
other causes (n = 16). Baseline data of the patients are shown
in Table 2. The severely injured patients (mean ISS 25.5 ± 8.2)
were mostly young (38.5 ± 11.5 years). One hundred and forty
seven patients (47.7%) developed sepsis. Two hundred and
fifty five (82.8%) patients developed organ dysfunction,
among whom one hundred and sixty (52%) had two or more
organ dysfunctions. The mean time to MODS was 4.4 ± 3.5
days. The mean number of operations performed per patient
was 3.5 ± 3.2 (range 1 to 14). Substitution of erythrocytes
was necessary in every patient (mean 5.4 ± 5.2 L). All of the
patients survived at least 48 hours after admission and com-
pleted genotyping.
Table 1
Primers and endonucleases for genotyping of IL-10 promoter single nucleotide polymorphisms
SNPs Primers PCR conditions Restriction endonucleases
-1082A/G F:ACACAAATCCAAGACAACACTACTAA
GGCTTCCTTGGGA
3 minutes at 94°C followed by 35 cycles of 40 seconds 
at 94°C, 45 seconds at 56°C, 40 seconds at 72°C, 
then 10 minutes at 72°C
XagI
R:GTGATCAAACAGAGGCACAGACAT
-819T/C F:CACTCTAAGGCTTCCTTGGGA 3 minutes at 94°C followed by 35 cycles of 40 seconds 
at 94°C, 45 seconds at 56°C, 40 seconds at 72°C, 
then 10 minutes at 72°C
Hin1α
R:CCTACCGTCTCTATTTTATAGTGAGC
AAACTGAGGCACAGACAT
-592 A/C F:AGCTGAAGAGGTGGAAACATGTG 3 minutes at 94°C followed by 35 cycles of 40 seconds 
at 94°C, 45 seconds at 63°C, 40 seconds at 72°C, 
then 10 minutes at 72°C
Rsa I
R:TGGGTTCTCATTCGCGTGTTCritical Care    Vol 13 No 6    Zeng et al.
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Allele frequencies and genotype distribution
The overall minor allele frequencies were 15.4%, 29.2% and
34% for the -1082G, -819C and -592C alleles, respectively,
in our cohort. The genotype frequencies of these three SNPs
were in agreement with the Hardy-Weinberg equilibrium
(Table 3). These SNPs were completely (-819 to -592) or
strongly (-1082 to -819 and -592) linked. The three common
haplotypes with frequency of more than or equal to 10% were
-1082A/-819T/-592A (ATA, 49.5%), -1082A/-819T/-592C
(ATC, 14.1%) and -1082A/-819C/-592A (ACA, 13.1%),
respectively. With regard to the number of ATA haplotypes,
25.7% of the trauma patients had the genotype 0 ATA, 51.2%
had 1 ATA, and 23.1% had 2 ATA.
Association of the IL-10 promoter polymorphisms with 
IL-10 production
Given the possible functionality of the -1082, -819 and -592
polymorphisms, we hypothesized that these SNPs might
affect IL-10 production after trauma, leading to individual dif-
ference in plasma IL-10 levels in trauma patients. Peripheral
blood was taken immediately after admission in an attempt to
avoid the potential effects of non-genetic factors on IL-10 pro-
duction. As shown in Table 4, there were no significant differ-
ences in age, gender ratio and ISS scores among trauma
patients with different genotypes of the three polymorphisms.
Spontaneous IL-10 production was not significantly different
between different genotypes of all three loci (data not shown).
However, LPS-induced IL-10 production was shown to be sig-
nificantly different between different genotypes of the -1082
and -592 polymorphisms, showing that the -1082A and -592A
alleles were associated with lower IL-10 production (P  =
0.005 and P = 0.001, respectively by dominant effect). Data
from linear regression analysis indicated that the functional
association of these two polymorphisms with IL-10 production
was significantly allele-dose dependent (P = 0.003 and P =
Table 2
Overall clinical characteristics of patients with major trauma (n 
= 308)
Age (years) 38.5 ± 11.5 (18-65)
Male/female, n 240/68
ISS 25.5 ± 8.2
≥ 16, <25, n 143
≥ 25, n 165
Injured body regions
Head, n (AIS points) 115 (1.9 ± 1.7)
Thorax, n (AIS points) 123 (3.3 ± 1.3)
Abdomen, n (AIS points) 97 (3.0 ± 1.9)
Extremities, n(AIS points) 165 (2.2 ± 1.1)
Number of regions injured
Two, n 186
Three, n 99
All four, n 23
Organ dysfunction
One, n 95
Two, n 101
Three or above, n 59
Sepsis, n (%) 147(47.7)
AIS = Abbreviated Injury Scale; ISS = Injury Severity Scores.
Table 3
Distribution of the IL-10 promoter polymorphisms among trauma patients
Loci Patients n MA (%) Genotypes, n (%) HWE
wild heterozygous variant
A-1082G All 308 15.4 224 (72.7) 73 (23.7) 11 (3.6) 0.11
Sepsis 147 12.2 115 (78.2) 28 (19.1) 4 (2.7)
Non-sepsis 161 18.3a 109 (67.7)b 45 (28) 7 (4.3)
T-819C All 308 29.2 157 (51.0) 122 (39.6) 29 (9.4) 0.46
Sepsis 147 29.3 73 (49.7) 62 (42.2) 12 (8.2)
Non-sepsis 161 29.2 84 (52.2) 60 (37.3) 17 (10.6)
A-592C All 307 34.0 141 (45.9) 123 (40.1) 43 (14.0) 0.07
Sepsis 147 34.4 65 (44.2) 63 (42.9) 19 (12.9)
Non-sepsis 160 33.8 76 (47.5) 60 (37.5) 24 (15.0)
Sepsis vs. non-sepsis: aP = 0.037, bP = 0.038. HWE = Hardy-Weinberg equilibrium; MA = minor allele.Available online http://ccforum.com/content/13/6/R188
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0.037 for -1082 and -592, respectively). Although the -819T
allele is also associated with lower LPS-induced IL-10 produc-
tion, no significant difference was found between the different
genotype groups (Table 4). In case of a combination effect of
the three SNPs, we further analyzed the association of ATA
haplotype with IL-10 production. Table 5 showed that the pro-
duction of IL-10 was lowest in those with haplotype genotype
2 ATA, showing significant difference if compared with those
with genotype 0 ATA (P = 0.041). Data from linear regression
analysis indicated that this association with IL-10 production
were significantly haplotype-dose dependent (P = 0.041).
Association of the IL-10 promoter polymorphisms with 
development of sepsis and MODS in trauma patients
As shown in Table 4, there was a close association of the -
1082 polymorphism with the development of sepsis, showing
that the patients with the A allele had significantly higher sep-
sis morbidity (P = 0.038 for dominant effect). Data from multi-
ple logistical regression analyses indicated that A to G
variation at this position was borderline significantly associ-
ated with lower risk of sepsis (OR = 0.677, 95% CI = 0.453
to 1.011, P = 0.057). In addition, there was a borderline sig-
nificantly increasing trend of MODS scores in the patients with
the A allele at -1082 locus (P = 0.088 for recessive effect).
However, both of the -819 and -592 polymorphisms were not
Table 4
Clinical relevance of the IL-10 promoter polymorphisms in patients with major trauma
Genotypes N Age (years) Gender
(M/F)
ISS Sepsis(%) MOD score Cytokine (pg/ml)
-1082
AA 224 38.6 ± 14.1 177/47 25.6 ± 8.5 51.3 4.4 ± 2.7 62.0 ± 19.8
AG 73 37.3 ± 13.5 62/11 26.3 ± 7.5 38.4 5.4 ± 2.8 73.9 ± 21.3
GG 11 35.9 ± 20.3 7/4 27.2 ± 10.6 36.4 4.1 ± 2.9 86.0 ± 18.8
-819 a1 b1 a2, b2, c1
TT 157 37.6 ± 13.7 120/37 25.6 ± 8.8 46.5 4.6 ± 2.6 56.2 ± 17.8
TC 122 39.6 ± 14.6 100/22 25.9 ± 8.1 50.8 4.7 ± 2.8 59.9 ± 20.2
CC 29 35.7 ± 15.1 26/3 27.1 ± 7.9 41.4 4.4 ± 2.9 62.4 ± 19.5
-592
AA 141 38.2 ± 14.6 116/25 25.1 ± 7.9 46.1 4.5 ± 2.1 52.9 ± 16.0
AC 123 38.0 ± 13.2 98/25 27.1 ± 9.0 51.2 5.1 ± 3.0 66.8 ± 19.6
CC 43 36.8 ± 16.0 31/12 24.8 ± 8.0 44.2 4.1 ± 2.7 59.8 ± 13.1
a3, c2
a: dominant effect (variant homozygotes +heterozygotes vs. wild homozygotes) as analyzed by ANCOVA, a1P = 0.038, a2P = 0.005, a3P = 0.001.
b: recessive effect (variant homozygotes vs. heterozygotes + wild homozygotes) as analyzed by ANCOVA, b1P = 0.088, b2P = 0.083.
c: allele dose effect as analyzed by linear regression analysis, c1P = 0.003, c2P = 0.037.
ANCOVA = analysis of covariance; F = female; ISS = Injury Severity Score; M = male; MOD = multiple organ dysfunction.
Table 5
Clinical relevance of Interleukin-10 haplotypes in major trauma patients
Haplotype* Count IL-10 (pg/ml) MODS Sepsis (%)
0(ATA) 71 72.18 ± 22.51 4.25 ± 2.60 28 (39.4)
1(ATA) 157 65.19 ± 20.36 5.00 ± 2.89 76 (48.4)
2(ATA) 79 60.27 ± 19.24a, c 4.24 ± 2.39 43 (54.4)
*'0 ATA haplotype' includes the following genotypes: ATC/ATC, ATC/ACC, ACA/ACA, ACA/ACC, ACC/ACC, ATC/GTC, ATC/GCC, ACC/
GTC, ACA/GCA, ACC/GCA, ACA/GCC, ACC/GCC, GTA/GTC, GTC/GTC, GTA/GCC and GTC/GCA; '1 ATA haplotype' includes ATA/ATC, 
ATA/ACA, ATA/ACC, ATA/GTA, ATA/GTC, ATA/GCA and ATA/GCC; '2 ATA haplotype' is ATA/ATA. haplotype is indicated in an order of -
1082A, -819T and -592A.
a: 2 ATA vs 0 ATA, P = 0.041; c: haplotype dose effect, P = 0.041.
MODS = multiple-organ dysfunction syndrome.Critical Care    Vol 13 No 6    Zeng et al.
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shown to be significantly associated with the development of
sepsis and MODS in trauma patients.
Concerning the association of sepsis with allele and genotype
frequencies, there were no significant differences in allele and
genotype frequencies of the three polymorphic loci between
all trauma patients and trauma patients with sepsis. There was
a significant difference in the AA genotype frequency (P =
0.038) at position -1082 between patients with and without
sepsis. The frequency of the G allele was significantly higher
in patients without sepsis than in those with sepsis (P  =
0.037). No significant difference was observed between
patients with and without sepsis for the allele and genotype
frequencies of other two polymorphic loci (Table 3). With
respect to the combination effect of the three SNPs, although
there was a trend of increasing risk for sepsis incidence with
the number of ATA haplotype (39.4% for 0 ATA vs 54.4% for
2 ATA), no significant differences in MODS scores and sepsis
morbidity rate were observed between any haplotype groups
(Table 5).
Discussion
The aim of the present study was to estimate the clinical rele-
vance of the IL-10 promoter polymorphisms in patients with
major trauma. The described genotype and allele frequencies
of the IL-10 polymorphisms studied in this cohort are quite
similar to previously reported distributions in other studies in
Chinese patients [18-20,25] and other Asian populations
[30]. The minor alleles at positions -819 and -592 are the C
allele in Asian populations [18-20,25,30], which is different to
those seen in Western populations, being T and A alleles,
respectively [22-24,26,31]. Although the minor allele at posi-
tion -1082 is G in both Asian and Western populations, its fre-
quency is quite different, over 40% in Western populations
[21,22,26,31,32] and about 10% in Asian populations [19-
21]. This leads to quite a difference in the common haplotypes
between Asian and Western populations. Three common hap-
lotypes in this cohort are ATA, ATC and ACA, respectively,
while GCC, ATA and ACC are the common haplotypes in
Western populations. The differences in allele prevalence
might be due to ethnic difference [33].
It has been shown that about 75% of the variation in IL-10 pro-
duction is genetically determined [13]. IL-10 production
appears to be controlled at the transcriptional level [34]. The -
1082, -819 and -592 polymorphisms have been shown to
affect promoter activity, showing that the ATA haplotype is
associated with the lowest transcription activity [19]. Results
from bioinformatics analysis indicates that base pair substitu-
tions at positions -1082, -819 and -592 might affect putative
transcription factor binding, such as C/EBP beta, GATA-bind-
ing factor 2, Ets and STAT3 [35]. Given the functionality of the
IL-10 promoter SNPs, we investigate whether these SNPs
affect IL-10 production in response to a known stimulus such
as LPS immediately after trauma. In the case of the effect of
individual SNP, our results indicate that both of the -1082 A
and -592 A alleles are shown to be associated with LPS-
induced IL-10 production. However, there is no association for
the -819 polymorphism. Our results are in agreement with pre-
vious reports [15,34], but in contrast to the results reported by
Keijsers and colleagues [36] and Rad and colleagues [37].
They showed that the A allele at -1082 and the T allele at -819
were associated with higher and lower IL-10 production,
respectively. Similar to their effect on transcription, LPS-stim-
ulating production of IL-10 by peripheral blood leukocytes is
lowest in patients with combined genotype 2 ATA, which is
significantly different compared with patients with genotype 0
ATA. The ATA haplotype has been demonstrated to have low-
est transcriptional activity [19]. Our results further confirm the
functionality of the IL-10 promoter SNPs in relation to IL-10
production. It also suggests that individual differences in IL-10
production in trauma patients might be at least in part related
to genetic variations in the IL-10 promoter region.
Given the functional significance of the -1082 and -592 poly-
morphisms and ATA haplotype, we further hypothesized that
the IL-10 promoter polymorphisms would be important in influ-
encing severity to the development of sepsis and MODS in
trauma patients by changing the balance of pro-inflammatory
and anti-inflammatory cytokines. There were no significant dif-
ferences in age, gender ratio and ISS scores among the differ-
ent genotype groups, which minimized the influence of
interfering factors. The patient cohort consisted of young
patients with a low background of coexisting morbidity. Similar
to their association with IL-10 production, genetic variations at
the three loci have a trend to be associated with lower risk of
sepsis and MODS. However, only the -1082 polymorphism
has statistical significance, showing that the patients with the
A allele had significantly higher sepsis morbidity and a border-
line significant increase in MODS scores. There are also sig-
nificant differences in the frequencies of the allele and AA
genotype at this polymorphic locus between patients with sep-
sis and non-sepsis. The finding of no significant difference in
the GG genotype frequency might be due to a small number
of patients carrying the GG genotype in the current study.
Results from Stanilova and colleagues [22] also revealed that
the AA genotype of the -1082 locus was associated with
lower IL-10 production in LPS-, phytohemagglutinin- or
pokeweed mitogen-stimulated healthy peripheral blood leuko-
cytes. Patients with severe sepsis were shown to have a sig-
nificant elevation of A allele frequency when compared with
healthy controls. In addition, Gong and colleagues [21] further
reported that the high IL-10-producing -1082 GG genotype
was protective against organ failure and mortality in acute res-
piratory distress syndrome. It is increasingly recognized that
the overall balance between pro-inflammatory and anti-inflam-
matory responses is important in the development of sepsis
and MODS after trauma. Therefore, it is reasonable that lower
IL-10-producing -1082 AA genotype might be used as a rele-
vant risk estimate for organ dysfunction and sepsis in traumaAvailable online http://ccforum.com/content/13/6/R188
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patients. This is not consistent with the report by Schroeder
and colleagues, which showed that the -592 polymorphism,
but not -1082, was associated with MODS in patients with
major trauma [23]. The different patient populations studied
may explain this discrepancy. With respect to the combination
effect, our results show that the patients with 2 ATA haplo-
types have higher sepsis morbidity rates, but this lacks statis-
tical significance, although it is significantly associated with
lower IL-10 production. This is in accordance with previous
reports [38]. It suggests that there is a lack of synergistic
effect among the -1082, -819 and -592 polymorphisms in rela-
tion to the development of sepsis and MODS in trauma
patients. Other pathogenic factors should be also considered
when explaining the current results. One important factor is
the polygenetic and multifactorial involvement in the pathogen-
esis of sepsis and multiple organ dysfunction after trauma
[39]. In fact, there is increasing evidence indicating that
genetic polymorphisms of other genes are associated with the
occurrence of post-traumatic complications, such as IL-1β,
TNFα, heat shock protein 70, IFN-γ and IL-18 [40,41]. The
susceptibility to sepsis and organ dysfunction in trauma
patients might be the result of a combination of numerous
genetic polymorphisms. In addition, the relatively small sample
size we recruited in this study might also affect our conclu-
sions. Our sample, although being considered adequate by
means of the Power and Sample Size program, just has a size
of about 300 patients, among which only 147 and 160
patients had sepsis and MODS, respectively. Further studies
are needed to confirm the clinical relevance of the IL-10 pro-
moter polymorphisms in a larger cohort of trauma patients and
to investigate the relation of these SNPs with other genetic
polymorphisms in prediction of sepsis and outcome in trauma
patients.
Conclusions
The present study investigated the clinical relevance of the
genetic variations at positions -1082, -819 and -592 in the IL-
10 promoter in patients with major trauma. These genetic var-
iations are shown to affect IL-10 production after trauma, and
to be associated with risk for the development of post-trau-
matic sepsis and MODS at different degrees. Further studies,
both clinical and experimental, are therefore needed to confirm
the significance of these findings and to investigate their syn-
ergistic effect with other genetic polymorphisms in relation to
the development of sepsis and outcome in trauma patients.
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